Back to Search
MAIA WIESENFELD, DMD
DMD
Pediatric Dentistry
NPI: 1306533534Individual
Specialties, Licenses & Credentials
Research & Publications (14)
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
PMID 19066728·J Neurooncol·2009
3-trial
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.
PMID 19047293·J Clin Oncol·2009
3-trial
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
PMID 17613756·Leuk Lymphoma·2007
3-trial
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.
PMID 17187355·Int J Cancer·2007
8-other
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study.
PMID 16085692·Ann Oncol·2005
3-trial
Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
PMID 15117979·J Clin Oncol·2004
4-observational
Weekly carboplatin and paclitaxel in elderly non-small-cell lung cancer patients (>or=65 years of age): a phase II North Central Cancer Treatment Group study.
PMID 14528068·Am J Clin Oncol·2003
3-trial
Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
PMID 12796591·Am J Clin Oncol·2003
3-trial
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting.
PMID 12745490·Nicotine Tob Res·2003
3-trial
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.
PMID 12649105·Ann Oncol·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
Via practice · 2 locations total
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-3887
Quick Facts
- NPI
- 1306533534
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 14
Are you this provider?
Claim Your Profile